Search results for: Health Policy and Regulation
Filter search results
New Research on VBP: Disease Severity and Unmet Need in the UK
24 April 2012
…been studied adequately (or perhaps at all) to date, either in the UK or elsewhere. The Department of Health’s Policy Research Unit in Economic Evaluation of Health and Care Interventions…
OHE has an Opening for an Economist — Consultancy and Research
23 May 2012
…research and consultancy activities. Our work covers a broad range of analyses into the economics and policy of: (1) health care systems, (2) pharmaceutical and other life sciences industries, and…
Register Now for the OHE Conference on Drug Development in 2022
14 August 2012
…of UK and EU regulatory agencies, the pharmaceutical industry and payers — as well as leading experts in health technology assessment, pricing and reimbursement, and R&D structure and incentives. Among…
OHE Conference on the Future of Drug Development – Register Now
5 September 2012
…of UK and EU regulatory agencies, the pharmaceutical industry and payers — as well as leading experts in health technology assessment, pricing and reimbursement, and R&D structure and incentives. Among…
Join OHE in a Seminar to Discuss IP, Innovation and the Human Genome
19 October 2012
…in the context of existing theoretical and empirical research, and comment on the implications of these findings for public policy. Prof Williams is an Assistant Professor of Economics at the…
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
1 July 2019
…launch of new and more effective presentations and indications. Consequently, we suggest that pricing and reimbursement decisions should consider how to recognise the dynamic nature of pharmaceutical markets and the…
Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures
1 February 2019
…evaluate the clinical and economic value of health care interventions − prescription drugs, diagnostic tests, and a range of others − and innovations in the delivery of care. ICER involves…
OHE This Week: BioWales 2013, UK Medicines Market and EQ-5D in Asia
18 March 2013
…March: Nancy Devlin will be in Singapore with EuroQol colleagues. The symposium with Asian researchers and policy makers will discuss the EQ-5D and explore its potential in Asia. Until 12…
The Road to Sustainability in the UK and German Biotechnology Industries
1 August 2000
The UK and Germany are the European leaders in biotechnology. They have many more companies and employees in biotechnology, and much greater sums invested in biotechnology research and development (R&D)…